Hong Xiang

3PUBLICATIONS
0CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 01, 2021
Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer.

Hong Xiang, Abigael G Chan, Ago Ahene

|Aug 12, 2021
Covariate effects and population pharmacokinetic analysis of the anti-FGFR2b antibody bemarituzumab in patients from phase 1 to phase 2 trials.

Hong Xiang, Lucy Liu, Yuying Gao

|Sep 23, 2020
Population pharmacokinetic analysis of phase 1 bemarituzumab data to support phase 2 gastroesophageal adenocarcinoma FIGHT trial.

Hong Xiang, Lucy Liu, Yuying Gao

Pageof 1

Frequent Collaborators